|
Number of patients
|
7080
|
1733
|
1542
|
1556
|
1601
|
648
|
|
Demographic factors
|
|
Age, mean ± SD, years
|
71.4 ± 11.9
|
73.7 ± 12.5
|
70.4 ± 12.2
|
70.4 ± 11.6
|
71.1 ± 11.1
|
70.3 ± 11.1
|
|
Gender (% male)
|
65.7
|
63.1
|
67.1
|
66.3
|
65.5
|
69.0
|
|
Material status, n (%)
|
|
Single
|
914 (12.9)
|
235 (13.6)
|
227 (14.7)
|
180 (11.6)
|
189 (11.8)
|
83 (12.8)
|
|
Married
|
3626 (51.2)
|
797 (46.0)
|
806 (52.3)
|
843 (54.2)
|
842 (52.6)
|
338 (52.2)
|
|
Divorce
|
1158 (16.4)
|
284 (16.4)
|
236 (15.3)
|
242 (15.6)
|
284 (17.7)
|
112 (17.3)
|
|
Widow/widower
|
1368 (19.3)
|
411 (23.7)
|
271 (17.6)
|
288 (18.5)
|
283 (17.7)
|
115 (17.8)
|
|
Missing
|
14 (0.2)
|
6 (0.3)
|
2 (0.1)
|
3 (0.2)
|
3 (0.2)
|
0 (0.0)
|
|
Education level, n (%)
|
|
< =9 years
|
3070 (43.4)
|
778 (44.9)
|
655 (42.5)
|
643 (41.3)
|
700 (43.7)
|
294 (45.4)
|
|
10–12 years
|
2561 (36.2)
|
586 (33.8)
|
545 (35.3)
|
578 (37.2)
|
600 (37.5)
|
252 (38.9)
|
|
> =12 years
|
1038 (14.7)
|
227 (13.1)
|
239 (15.5)
|
255 (16.4)
|
235 (14.7)
|
82 (12.7)
|
|
Missing
|
411 (5.8)
|
142 (8.2)
|
103 (6.7)
|
80 (5.1)
|
66 (4.1)
|
20 (3.1)
|
|
Disease-related factors
|
|
Time of follow-up (months, until death, emigration or the end of study)
|
|
Mean ± SD
|
15.6 ± 18.0
|
10.4 ± 16.1
|
13.0 ± 15.8
|
16.3 ± 17.7
|
18.5 ± 18.0
|
26.6 ± 21.5
|
|
Hospital Volume
| | | | | | |
|
Low (<20 cases/year)
|
3310 (46.8)
|
975 (56.3)
|
749 (48.6)
|
664 (42.7)
|
659 (41.2)
|
263 (40.5)
|
|
Median (20–40 cases/year)
|
1868 (26.4)
|
442 (25.5)
|
456 (29.5)
|
420 (27.0)
|
387 (24.1)
|
163 (25.2)
|
|
High (>40 cases/year)
|
1899 (26.8)
|
314 (18.1)
|
337 (21.9)
|
471 (30.3)
|
555 (34.7)
|
222 (34.3)
|
|
Missing
|
2 (0.0)
|
0 (0.0)
|
1 (0.0)
|
0 (0.0)
|
0 (0.0)
|
3 (0.0)
|
|
ASA physical status, n (%)
|
|
I-II
|
4319 (61.0)
|
902 (52.1)
|
970 (62.9)
|
1023 (65.8)
|
1030 (64.3)
|
394 (60.7)
|
|
III-IV
|
2588 (36.6)
|
791 (45.6)
|
529 (34.3)
|
494 (31.8)
|
539 (33.7)
|
235 (36.3)
|
|
Missing
|
173 (2.4)
|
40 (2.3)
|
43 (2.8)
|
39 (2.4)
|
32 (2.0)
|
19 (2.9)
|
|
Cancer type, n (%)
|
|
Gastric cancer
|
3562 (50.3)
|
1004 (57.9)
|
788 (51.1)
|
737 (47.4)
|
715 (44.7)
|
318 (49.1)
|
|
Esophageal cancer
|
3518 (49.7)
|
729 (42.1)
|
754 (48.9)
|
819 (52.6)
|
886 (55.3)
|
330 (50.9)
|
|
Cancer stage, n (%)
|
|
Stage 0
|
191 (2.70)
|
24 (1.38)
|
24 (1.56)
|
29 (1.86)
|
52 (3.25)
|
62 (9.57)
|
|
Stage I
|
905 (12.8)
|
131 (7.56)
|
157 (10.2)
|
226 (14.5)
|
260 (16.2)
|
131 (20.2)
|
|
Stage II
|
924 (13.1)
|
155 (8.94)
|
200 (13.0)
|
252 (16.2)
|
236 (14.7)
|
81 (12.5)
|
|
Stage III
|
2824 (39.9)
|
688 (39.7)
|
601 (39.0)
|
615 (39.5)
|
671 (41.9)
|
249 (38.4)
|
|
Stage IV
|
2188 (30.9)
|
726 (41.9)
|
557 (36.1)
|
423 (27.2)
|
369 (23.1)
|
113 (17.4)
|
|
Missing
|
48 (0.7)
|
9 (0.5)
|
3 (0.2)
|
11 (0.7)
|
13 (0.8)
|
12 (1.9)
|
|
Admission type, n (%)
|
|
GP referral
|
5406 (76.4)
|
1071 (61.8)
|
1128 (73.2)
|
1303 (83.7)
|
1367 (85.4)
|
537 (82.9)
|
|
Emergency intake
|
1517 (21.4)
|
627 (36.2)
|
367 (23.8)
|
225 (14.5)
|
201 (12.6)
|
97 (15.0)
|
|
Missing
|
157 (2.2)
|
35 (2.0)
|
47 (3.0)
|
28 (1.8)
|
33 (2.0)
|
14 (2.1)
|
|
Treatment decided through multidisciplinary conference, n (%)
|
|
Yes
|
4080 (57.6)
|
668 (38.6)
|
929 (60.3)
|
990 (63.6)
|
1074 (67.1)
|
419 (64.7)
|
|
No
|
2953 (41.7)
|
1053 (60.8)
|
599 (38.9)
|
556 (35.7)
|
521 (32.5)
|
224 (34.6)
|
|
Missing
|
47 (0.7)
|
12 (0.6)
|
14 (0.8)
|
10 (0.7)
|
6 (0.4)
|
5 (0.7)
|
|
Planned treatment type, n (%)
|
|
Curative
|
3038 (42.9)
|
484 (27.9)
|
607 (39.4)
|
783 (50.3)
|
824 (51.5)
|
340 (52.5)
|
|
Palliative
|
2631 (37.2)
|
714 (41.2)
|
663 (43.0)
|
547 (35.2)
|
548 (34.2)
|
159 (24.5)
|
|
Supportive
|
1400 (19.8)
|
531 (30.6)
|
271 (17.6)
|
226 (14.5)
|
227 (14.2)
|
145 (22.4)
|
|
Missing
|
11 (0.1)
|
4 (0.3)
|
1 (0.0)
|
0 (0.0)
|
2 (0.1)
|
4 (0.6)
|
